LT3473B - Tryciclic pyridone derivative - Google Patents

Tryciclic pyridone derivative Download PDF

Info

Publication number
LT3473B
LT3473B LTIP801A LTIP801A LT3473B LT 3473 B LT3473 B LT 3473B LT IP801 A LTIP801 A LT IP801A LT IP801 A LTIP801 A LT IP801A LT 3473 B LT3473 B LT 3473B
Authority
LT
Lithuania
Prior art keywords
compound
formula
compound according
preparation
ethyl
Prior art date
Application number
LTIP801A
Other languages
English (en)
Lithuanian (lt)
Inventor
Richard Raimund Scherschlicht
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LTIP801A publication Critical patent/LTIP801A/xx
Publication of LT3473B publication Critical patent/LT3473B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
LTIP801A 1991-01-25 1993-07-20 Tryciclic pyridone derivative LT3473B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22891 1991-01-25

Publications (2)

Publication Number Publication Date
LTIP801A LTIP801A (en) 1995-02-27
LT3473B true LT3473B (en) 1995-10-25

Family

ID=4182207

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP801A LT3473B (en) 1991-01-25 1993-07-20 Tryciclic pyridone derivative

Country Status (30)

Country Link
US (2) US5281711A (cs)
EP (1) EP0496274B1 (cs)
JP (1) JPH0739415B2 (cs)
KR (1) KR920014811A (cs)
AT (1) ATE140002T1 (cs)
AU (1) AU649302B2 (cs)
BG (1) BG61057B2 (cs)
BR (1) BR9200217A (cs)
CA (1) CA2058640A1 (cs)
CZ (1) CZ280258B6 (cs)
DE (1) DE59206676D1 (cs)
DK (1) DK0496274T3 (cs)
ES (1) ES2089252T3 (cs)
FI (1) FI920268A7 (cs)
GR (1) GR3021126T3 (cs)
HU (2) HU207072B (cs)
IE (1) IE920225A1 (cs)
IL (1) IL100702A (cs)
IS (1) IS3804A (cs)
LT (1) LT3473B (cs)
LV (1) LV10275B (cs)
MX (1) MX9200242A (cs)
MY (1) MY108199A (cs)
NO (1) NO920338L (cs)
NZ (1) NZ241341A (cs)
RU (1) RU2073678C1 (cs)
SI (1) SI9210067A (cs)
UY (1) UY23362A1 (cs)
YU (1) YU48221B (cs)
ZA (1) ZA92361B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법
US7277767B2 (en) 1999-12-10 2007-10-02 Srs Labs, Inc. System and method for enhanced streaming audio
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
DE602006004009D1 (de) * 2005-08-06 2009-01-15 Cambridge Lab Ireland Ltd 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen
WO2010058429A1 (en) 2008-11-24 2010-05-27 Council Of Scientific & Industrial Research A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines
WO2014190140A1 (en) 2013-05-23 2014-11-27 Alan Kraemer Headphone audio enhancement system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191427B (en) * 1984-07-16 1987-02-27 Budapesti Mueszaki Egyetem,Hu Piezooptical effect reduced electrooptical light modulator
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
ZW17385A1 (en) * 1984-11-06 1986-02-19 Hoffmann La Roche Tricyclic pyridine derivatives
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K. TAMAZAWA ET AL.: "Research Article Prev. Article Next Article Table of Contents Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate", J. MED.CEM., 1986, pages 2504 - 2511

Also Published As

Publication number Publication date
DE59206676D1 (de) 1996-08-08
LV10275B (en) 1995-02-20
HU207072B (en) 1993-03-01
MX9200242A (es) 1992-07-01
UY23362A1 (es) 1992-07-21
KR920014811A (ko) 1992-08-25
HU211259A9 (en) 1995-11-28
SI9210067A (en) 1995-02-28
MY108199A (en) 1996-08-30
HU9200128D0 (en) 1992-04-28
ZA92361B (en) 1992-09-30
FI920268L (fi) 1992-07-26
CZ280258B6 (cs) 1995-12-13
RU2073678C1 (ru) 1997-02-20
NO920338L (no) 1992-07-27
NZ241341A (en) 1993-12-23
BR9200217A (pt) 1992-10-06
YU48221B (sh) 1997-08-22
US5326769A (en) 1994-07-05
JPH04312585A (ja) 1992-11-04
DK0496274T3 (da) 1996-09-23
IE920225A1 (en) 1992-07-29
EP0496274B1 (de) 1996-07-03
US5281711A (en) 1994-01-25
LTIP801A (en) 1995-02-27
BG61057B2 (bg) 1996-09-30
YU6792A (sh) 1994-11-15
CS18292A3 (en) 1992-08-12
FI920268A7 (fi) 1992-07-26
ES2089252T3 (es) 1996-10-01
IS3804A (is) 1992-07-26
LV10275A (lv) 1994-10-20
JPH0739415B2 (ja) 1995-05-01
FI920268A0 (fi) 1992-01-22
AU649302B2 (en) 1994-05-19
GR3021126T3 (en) 1996-12-31
ATE140002T1 (de) 1996-07-15
IL100702A0 (en) 1992-09-06
NO920338D0 (no) 1992-01-24
IL100702A (en) 1995-08-31
EP0496274A1 (de) 1992-07-29
CA2058640A1 (en) 1992-07-26
AU1034092A (en) 1992-07-30
HUT60266A (en) 1992-08-28

Similar Documents

Publication Publication Date Title
US6391906B2 (en) Crystals of celecoxib
JPS5989625A (ja) 芳香族置換環状アミジン止瀉剤
JPH0780831B2 (ja) 新規のナフチルエチル尿素およびナフチルエチルチオ尿素、それらの製造方法、ならびにそれらを含む薬剤組成物
JPH08325217A (ja) 新規なアルコキシアリール化合物、その製造方法及びそれらを含む医薬組成物
US6689808B2 (en) Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
LT3473B (en) Tryciclic pyridone derivative
US5002946A (en) Phenylethanolamine analog active compounds for the treatment of gastrointestinal diseases
JPS61103893A (ja) Ｎ↑６‐トリサイクリツクアデノシン類
CH648283A5 (fr) Acides 2-amino-3-(alpha-hydroxybenzyl)-phenylacetiques et sels metalliques, esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant.
FR2600061A1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
HU211155A9 (en) Benzene derivatives, process for preparing them and pharmaceutical compositions containing them
JP2001501221A (ja) Ｎｍｄａ（ｎ―メチル―ｄ―アスパラギン酸）アンタゴニスト
EP0671173A1 (fr) Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs
US3467755A (en) Compositions and methods for producing sedation and tranquilization with substituted 4,5,6,7- tetrahydro-4-oxindoles
DE69526668T2 (de) Heterocyclisch substituierte propensäure derivate als nmda antagonisten
US4883822A (en) Agent for regulating the motional function of gastrointestinal tract
JPH0692948A (ja) 新規なアセタミド誘導体及びその用途
SK61597A3 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
HU184791B (en) Process for preparing derivatives of tetrahydro-pyrid-4-yl-indole
US3639457A (en) N-substituted-beta-oxybutyramide semisuccinate and its salt having effects of increasing paradoxical sleep and tranquillizing
US3958011A (en) Compositions of tri-n-propylacetic acid and salts thereof and treatment of neurological disorders with such compositions
US4067985A (en) Lactum drug compositions
EA008144B1 (ru) Применение производных индазола для лечения невропатической боли
JPH0136820B2 (cs)
HU186180B (en) Process for producing 3,7a-diaza-cyclohepta-bracket-j,k-bracket closed-fluorene derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19970720